An Outbreak of Community-Onset Methicillin-Resistant Staphylococcus aureus Skin Infections in Southwestern Alaska
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective: We investigated a large outbreak of community-onset methicillin-resistant Staphylococcus aureus(MRSA) infections in southwestern Alaska to determine the extent of these infections and whether MRSA isolates were likely community acquired. Design: Retrospective cohort study. Setting: Rural southwestern Alaska. Patients: All patients with a history of culture-confirmed S.aureus infection from March 1, 1999, through August 10, 2000. Results: More than 80% of culture-confirmed S.aureus infections were methicillin resistant, and 84% of MRSA infections involved skin or soft tissue; invasive disease was rare. Most (77%) of the patients with MRSA skin infections had communityacquired MRSA (no hospitalization, surgery, dialysis, indwelling line or catheter, or admission to a long-term-care facility in the 12 months before infection). Patients with MRSA skin infections were more likely to have received a prescription for an antimicrobial agent in the 180 days before infection than were patients with methicillin-susceptible S.aureus skin infections. Conclusions: Our findings indicate that the epidemiology of MRSA in rural southwestern Alaska has changed and suggest that the emergence of community-onset MRSA in this region was not related to spread of a hospital organism. Treatment guidelines were developed recommending that beta-lactam antimicrobial agents not be used as a first-line therapy for suspected S. aureus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Groom, A. V. (2001) · JAMA · doi:10.1001/jama.286.10.1201 · Cited by 360
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
SARAVOLATZ, L. D., POHLOD, D. J., & ARKING, L. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-325 · Cited by 290
Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins
Prevost, G., Couppie, P., Prevost, P., Gayet, S., Petiau, P., Cribier, B., Monteil, H., & Piemont, Y. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-42-4-237 · Cited by 269
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H., & Pringle, M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-13 · Cited by 1,262
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
“8% of MRSA isolates in this study were fully susceptible to levofloxacin, which is lower than in other studies that reported fluoroquinalone susceptibility among community-associated MRSA, where susceptibility to ciprofloxacin ranged from 79%(6) to 98%(14) to 100%.(15) As in other studies of community-associated MRSA,…”
BackgroundResultCommunity-acquired methicillin-resistant Staphylococcus aureus
Elston, D. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.04.018 · Cited by 308
Baggett, H. C., Hennessy, T. W., Rudolph, K., Bruden, D., Reasonover, A., Parkinson, A., Sparks, R., Donlan, R. M., Martinez, P., Mongkolrattanothai, K., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/383247 · Cited by 248
“These findings are consistent with the observation that the number of staphylococcal skin infections and MRSA isolates increased concurrently in the region during the start of the outbreak in 1999 [14].”
BackgroundResultInfluentialSelf-citationHuang, H., Flynn, N. M., King, J. H., Monchaud, C., Morita, M., & Cohen, S. H. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00254-06 · Cited by 186
Gorwitz, R. J. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815819bb · Cited by 164
“1 available online only).(9,22) MRSA skin lesions frequently are confused with spider bites by both patients and clinicians, even in areas of the country where spiders capable of causing necrotic skin lesions are not endemic.”
BackgroundInjecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection
Huang, H., Cohen, S. H., King, J. H., Monchaud, C., Nguyen, H., & Flynn, N. M. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.11.001 · Cited by 32
Metadata
- Authors
- Baggett, H. C., Hennessy, T. W., Leman, R., Hamlin, C., Bruden, D., Reasonover, A., Martinez, P., & Butler, J. C.
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2003-06
- Volume
- 24
- Issue
- 6
- Pages
- 397-402
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2112596072
- Cited by
- 143
- References
- 5
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.